SCHEMBL7412709

SCHEMBL7412709

CCOC(=O)c1cnc2ccccc2c1OCCl

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.58
MEN1 O00255 4/20 0.58
PKM P14618 1/20 0.58
ALDH1A1 P00352 7/20 0.52
MAPT P10636 7/20 0.52
KDM4E B2RXH2 4/20 0.52
NPSR1 Q6W5P4 2/20 0.52
TP53 P04637 1/20 0.51
SMN1; SMN2 Q16637 4/20 0.50
RXFP1 Q9HBX9 1/20 0.50
AURKA O14965 2/20 0.49
AURKB Q96GD4 2/20 0.49
LMNA P02545 2/20 0.48
MAPK1 P28482 2/20 0.48
ATM Q13315 1/20 0.48
GAA P10253 1/20 0.47
TSHR P16473 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5504475 0.91 KMT2A (0.62) KMT2AMEN1PKMALDH1A1MAPT
SCHEMBL30631460 0.82 MEN1 (0.67) KMT2AMEN1PKMALDH1A1MAPT
SCHEMBL776014 0.82 MEN1 (0.67) KMT2AMEN1PKMALDH1A1MAPT
SCHEMBL15445432 0.82 KMT2A (0.64) KMT2AMEN1PKMALDH1A1MAPT
SCHEMBL29366579 0.81 KMT2A (0.63) KMT2AMEN1PKMALDH1A1MAPT
SCHEMBL393627 0.81 KMT2A (0.63) KMT2AMEN1PKMALDH1A1MAPT
SCHEMBL31312808 0.80 KMT2A (0.62) KMT2AMEN1PKMALDH1A1MAPT
SCHEMBL20494881 0.80 KMT2A (0.62) KMT2AMEN1PKMALDH1A1MAPT
SCHEMBL20495354 0.80 KMT2A (0.62) KMT2AMEN1PKMALDH1A1MAPT
SCHEMBL437783 0.80 KMT2A (0.67) KMT2AMEN1PKMALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999006401-A1 2-ARYL-2,5-DIHYDRO-PYRAZOLO[4,3-c]QUINOLIN-3-ONES AS GABA ALPHA 5 RECEPTOR INVERSE AGONISTS MERCK SHARP & DOHME LIMITED (GB) 1999-02-11 WO disclosed